1. Too soon to market;Dent;BMJ,1997
2. Including elderly people in clinical trials;Avorn;BMJ,1997
3. Drug effects in elderly subjects: from the pharmacologic target to the risk-benefit. Round Table 5 of the 16th National Clinical Pharmacology Workshop;Lassale;Thérapie,2001
4. Guideline for the study of drugs likely to be used in the elderly;Food and Drug Administration;J Geriatr Drug Ther,1990
5. European Agency for the Evaluation of Medicinal Products (EMEA). 1995 Note for guidance on studies in support of special populations: geriatric. CPMP/ICH/379/95. London [online]. Available from URL: http://www.emea.eu.int/pdfs/human/ich/037995en.pdf [Accessed 2004 May 19].